Back to Results
First PageMeta Content
Accountancy / Business / Financial ratios / Generally Accepted Accounting Principles / EV/EBITDA / Income / Earnings before interest / taxes / depreciation and amortization / P/E ratio / Compound annual growth rate / Finance / Fundamental analysis / Valuation


DIVI[removed]MOSL-RU-8PG.p65
Add to Reading List

Document Date: 2012-02-01 02:19:28

Open Document

File Size: 238,37 KB

Share Result on Facebook

Company

Marco Polo Securities Inc. / S&P / INR621m / Bloomberg / Company Description Divi's Labs / Divi's Laboratories Divi's Laboratories / Divis Labs / Motilal Oswal Securities Limited / BASF / /

Country

United States / United Kingdom / India / /

Currency

USD / /

/

Event

Earnings Guidance / /

/

IndustryTerm

innovator pharmaceutical / contract manufacturing space / increased pharmaceutical outsourcing / value chain / /

Organization

U.S. Securities and Exchange Commission / NASD / FINRA / Divi's Lab / /

Person

Nimish Desai / /

/

Position

No No No No Analyst / independent financial advisor / research analyst / Analyst / Major Institutional Investors / registered broker-dealer in the United States / /

Technology

drug discovery / API / CMP / /

SocialTag